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The purpose of this study was to examine the occurrence of fosfomycin-resistant
Escherichia coli from chickens and to characterize the plasmids carrying fosA3. A total
of 661 E. coli isolates of chicken origin collected from 2009 to 2011 were screened
for plasmid-mediated fosfomycin resistance determinants by PCR. Plasmids were
characterized using PCR-based replicon typing, plasmid multilocus sequence typing, and
restriction fragment length polymorphisms. Associated addiction systems and resistance
genes were identified by PCR. PCR-mapping was used for analysis of the genetic context
of fosA3. Fosfomycin resistance was detected in 58 isolates that also carried the fosA3
gene. Fifty-seven, 17, and 52 FosA3-producers also harbored blaCTX−M, rmtB, and floR
genes, respectively. Most of the 58 fosA3-carrying isolates were clonally unrelated, and
all fosA3 genes were located on plasmids belonged to F33:A-:B- (n = 18), IncN-F33:A-:
B- (n = 7), IncHI2/ST3 (n = 10), IncI1/ST71 (n = 3), IncI1/ST108 (n = 3), and others. The
genetic structures, IS26-ISEcp1-blaCTX M bla−55-orf477 -− TEM 3−1-IS26-fosA -1758bp-IS26
and ISEcp1-blaCTX M 65-IS903-iroN-IS26-fosA3-536bp-IS26 were located on highly similar− −
F33:A-:B- plasmids. In addition, blaCTX M 14-fosA3-IS26 was frequently present on− −
similar IncHI2/ST3 plasmids. IncFII plasmids had a significantly higher frequency of
addiction systems (mean 3.5) than other plasmids. Our results showed a surprisingly high
prevalence of fosA3 gene in E. coli isolates recovered from chicken in China. The spread
of fosA3 can be attributed to horizontal dissemination of several epidemic plasmids,
especially F33:A-:B- plasmids. Since coselection by other antimicrobials is the major
driving force for the diffusion of the fosA3 gene, a strict antibiotic use policy is urgently
needed in China.
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INTRODUCTION
The increasing occurrence of bacterial infections caused by mul-
tidrug resistant gram-negative Enterobacteriaceae (MDR-GNB)
has reignited interest in the old antibiotic, fosfomycin (Falagas
et al., 2010). In recent years, fosfomycin has been widely recom-
mended for treating uncomplicated urinary tract infection (UTI)
due to its ease of administration and powerful bactericidal activ-
ity against MDR-GNB, especially extended-spectrum β-lactamase
(ESBL)-producing and fluoroquinolone-resistant Escherichia coli
(Falagas et al., 2010; Gardiner et al., 2014; Karlowsky et al., 2014).
At the same time, occasional reports of fosfomycin-resistant E. coli
strains have emerged (Lee et al., 2012; Ho et al., 2013a; Lai et al.,
2014). Mutations in chromosomal genes are the main mecha-
nism for fosfomycin resistance in E. coli (Michalopoulos et al.,
2011). However, the transferable fosfomycin resistance genes,
fosA, fosC2, and fosK, were recently identified in Asian countries
(Wachino et al., 2010; Hou et al., 2012, 2013; Lee et al., 2012;
Ho et al., 2013a,b; Kitanaka et al., 2014). Although fosfomycin
use in animals is prohibited in China, a high prevalence of the
plasmid-mediated fosfomycin-resistance gene fosA3was observed
in E. coli isolates from pet in China (Hou et al., 2012). We also
detected fosA3 in E. coli isolates from food animal recovered from
2004 to 2008, but with a relatively lower prevalence compared
with pet isolates (Hou et al., 2013). fosA3 is always co-transferred
with blaCTX−M genes and the dissemination of fosA3 among pet
isolates may be attributed to co-selection by cephalosporins (Hou
et al., 2012, 2013). The frequency of blaCTX−M in E. coli iso-
lated from food animals in China has generally been reported to
be low prior to 2008, but has increased in prevalence in recent
years, especially in chicken isolates (Liu et al., 2007; Li et al.,
2010; Zheng et al., 2012). To determine if the occurrence of
fosfomycin resistance has also increased with the increasing fre-
quency of blaCTX−M in food animal isolates in recent years, we
screened E. coli isolates of chicken origin collected during 2009–
2011 for fosfomycin resistance and plasmid-mediated fosfomycin
resistance genes. Characterization of fosA3-encoding plasmids as
well as the association of fosA3 with other resistance genes, such
as blaCTX−M, was also examined.
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MATERIALS AND METHODS
BACTERIAL ISOLATES
A total of 661 E. coli isolates were collected from healthy or
diseased chickens in China from 2009 to 2011. Two hundred
and ten E. coli from sick chickens at 57 farms were recov-
ered from clinical samples submitted to diagnostic laboratories
in Guangdong, Anhui, and Shandong province. The remain-
ing 451 isolates were obtained from fecal samples of healthy
chickens from 33 chicken farms located in different geographic
regions of China, including Jiangsu, Henan, Guangxi, Gansu, and
Guangdong provinces. Sample collection, culture, and E. coli iso-
lation were performed as described previously (Liu et al., 2007;
Zheng et al., 2012). E. coli isolates were identified by standard
biochemical tests. Assumed fosfomycin- resistant E. coli isolates
were selected using Mueller–Hinton (MH) agar plates supple-
mented with 128mg/L fosfomycin (Northeast Pharmaceutical
Group, Ltd) and 25μg/mL glucose-6-phosphate and subjected to
further study.
ANTIMICROBIAL SUSCEPTIBILITY TESTING
Antimicrobial susceptibility test was performed by the agar dilu-
tion method on Mueller–Hinton agar plates. The antimicro-
bial drugs tested included cefotaxime, fosfomycin, gentamicin,
amikacin, florfenicol, tetracycline, ciprofloxacin, colistin, and
imipenem. Moreover, the isolates were investigated for resistance
to tigecycline (15μg), and piperacillin/tazobactam (110μg) by
the agar disk diffusion method. Both susceptibility tests were car-
ried out and evaluated according to the protocols recommended
in VET01-S2 and M100-S23 of the Clinical and Laboratory
Standards Institute (2013a,b). E. coli ATCC 25922 was used as the
control strain.
DETECTION OF ANTIMICROBIAL RESISTANCE GENES
The assumed fosfomycin resistant E. coli isolates were screened
for the presence of the plasmid-mediated fosfomycin resistance
genes fosA3, fosC2, and fosA by PCR amplification using primers
described previously (Ho et al., 2013b). PCR results were con-
firmed by sequencing. The fosA3-positive strains were also eval-
uated for the presence of blaCTX−M, rmtB, and floR genes by
PCR (Chen et al., 2004, 2007; Sun et al., 2010). The genotype of
blaCTX−M was confirmed by PCR and DNA sequencing.
STRAIN TYPING
Pulse-field gel electrophoresis (PFGE) of XbaI digested genomic
DNA was carried out as described previously (Gautom, 1997)
using the CHEF-MAPPER System (Bio-Rad Laboratories, CA,
USA). PFGE patterns were analyzed with BioMumerics software
(Applied Maths) and were interpreted according to the well-
established criteria described by Tenover (Tenover et al., 1995).
Isolates that had PFGE patterns with no more than six differ-
ent bands were considered clonally related. Isolates were further
analyzed by multilocus sequence typing (MLST), which was
performed according to the specifications given at http://mlst.
warwick.ac.uk. MLST profiles were analyzed by Bionumerics.
CONJUGATION EXPERIMENTS AND PLASMID ANALYSIS
The transferability of fosA3 genes was investigated by conjuga-
tion experiments using streptomycin-resistant E. coli C600 as the
recipient strain. Transconjugants were selected on MacConkey
agar plates supplemented with fosfomycin (200μg/mL) and
streptomycin (2000μg/mL). Transfer frequencies were calculated
as the number of transconjugants per recipient. Transformation
experiments were performed to obtain a single plasmid carry-
ing fosA3, as verified by S1 nuclease PFGE when more than one
plasmid was co-transferred. The antimicrobial susceptibility of
the transconjugants/transformants was determined by the agar
dilution method, and the presence of fosA3, blaCTX−M, rmtB,
and floR in the transconjugants/transformants was confirmed
by PCR. PCR-based replicon typing (PBRT) was performed on
all transconjugants/transformants carrying a single plasmid, as
described by Carattoli et al. (2005). To better characterize IncFII,
IncI, and IncHI2 plasmids, replicon sequence typing (RST), plas-
mid multilocus sequence typing (pMLST), and plasmid double
locus sequence typing (pDLST) were performed according to the
procedure described previously (Garcia-Fernandez et al., 2008;
Garcia-Fernandez and Carattoli, 2010; Villa et al., 2010), and alle-
les were assigned by submitting the amplicon sequence to the
plasmid MLST database (www.pubmlst.org/plasmid/). F33:A-
:B-, IncI1, and IncHI2 plasmids carrying fosA3 were extracted
by a rapid alkaline lysis procedure (Takahashi and Nagano,
1984) and further compared using restriction fragment length
polymorphism (RFLP) analysis with EcoRI restriction enzymes.
ANALYSIS OF THE GENETIC ENVIRONMENT OF THE fosA3 GENE
The genetic context surrounding the fosA3 gene was investigated
by PCRmapping and sequencing. The primers used to determine
the regions upstream and downstream of the fosA3 genes are listed
in Table S1.
NUCLEOTIDE SEQUENCE ACCESSION NUMBERS
The new surrounding region of the fosA3 gene found in this study
has been deposited in the GenBank database under the following
accession numbers: KJ668701 and KJ668702.
RESULTS
PREVALENCE OF PLASMID-MEDIATED FOSFOMYCIN RESISTANCE
GENES
Of the 661 E. coli isolates from chicken examined, 58 (8.8%)
showed resistance to fosfomycin and carried the fosA3 gene.
These 58 isolates were recovered from chickens in 37 different
farms located in five provinces (Guangdong, Anhui, Shandong,
Guangxi, and Henan).
CHARACTERIZATION OF fosA3-CARRYING E. COLI ISOLATES
PFGE was successfully performed on 56 E. coli isolates carry-
ing fosA3, and 52 different XbaI PFGE patterns were identi-
fied (Table 1). Forty-four different sequence types (STs) were
detected among 58 fosA3-positive isolates, including 16 new STs
(Table 1 and Supplementary Figure S1). Isolates belonging to
ST48 (ST10 clonal complex) were detected in 6 isolates from 6
farms. Minimum spanning tree of MLST of 58 fosA3-carrying
E. coli isolates by Bionumerics.
Of the 58 FosA3-producing E. coli isolates examined in this
study, 58 (100%), 57 (98.3%), 57 (98.3%), 52 (89.7%), 49
(84.5%), 44 (75.9%), and 21 (36.2%) were resistant to ampicillin,
cefotaxime, tetracycline, florfenicol, ciprofloxacin, gentamicin,
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Table 1 | Characterization of fosA3-carrying E. coli isolates.
Isolatea Farmb Isolation date PFGE patternc MLST Resistance profiled
AHC8 F1 2011.6 1 ST4472 AMK, CTX, GEN, CIP, FFC, TET
AHC9 F1 2011.6 2 ST48 CTX, GEN, CIP, TET
AHC12 F1 2011.6 3 ST533 CTX, GEN, CIP, FFC, TET
AHC16 F2 2011.6 3 ST533 CTX, GEN, CIP, FFC, TET
AHC19 F4 2011.6 3 ST533 CTX, GEN, CIP, FFC, TET
AHC14 F1 2011.6 4 ST746 CTX, CIP, FFC, TET
AHC17 F2 2011.6 5 ST4483 AMK, CTX, GEN, CIP, FFC, TET
AHC18 F3 2011.6 6 ST4447 CTX, CIP, TET
AHC23 F5 2011.6 7 ST2607 AMK, CTX, GEN, CIP, FFC, TET
AHC24 F5 2011.6 8 ST155 AMK, CTX, GEN, CIP, FFC, TET
AHC26 F6 2011.6 9 ST23 AMK, CTX, GEN, CIP, TET
AHC27 F6 2011.6 10 ST2179 CTX, GEN, CIP, FFC, TET
AHC30 F6 2011.6 11 ST226 CTX, CIP, FFC, TET
AHC33 F7 2011.6 12 ST101 AMK, CTX, GEN, CIP, FFC, TET
AHC51 F9 2011.7 13 ST57 CTX, GEN, CIP, FFC, TET
AHC52 F9 2011.7 14 ST206 AMK, CTX, GEN, CIP, FFC, TET
AHC76 F8 2011.7 15 ST4466 AMK, CTX, GEN, CIP, FFC, TET
AHC54 F9 2011.7 16 ST155 AMK, CTX, GEN, CIP, TET
AHC55 F9 2011.7 17 ST162 CTX, GEN, CIP, FFC, TET
AHC57 F10 2011.7 18 ST10 AMK, CTX, GEN, FFC, TET
AHC60 F11 2011.7 19 ST48 AMK, GEN, CIP, FFC, TET
AHC66 F12 2011.7 20 ST48 CTX, GEN, CIP, FFC, TET
AHC67 F12 2011.7 21 ST2223 CTX, GEN, FFC, TET
AHC69 F13 2011.7 22 ST2847 CTX, CIP, FFC, TET
AHC72 F13 2011.7 23 ST2847 CTX, CIP, FFC, TET
AHC80 F14 2011.7 24 ST155 AMK, CTX, GEN, CIP, FFC, TET
GDC27 F15 2010.8 25 ST156 CTX, GEN, FFC, TET
GDC40 F16 2010.8 26 ST744 CTX, GEN, CIP, FFC, TET
GDC54 F18 2010.8 27b ST2496 CTX, GEN, CIP, FFC, TET
GDC46 F17 2010.8 27a ST4460 CTX, GEN, CIP, FFC, TET
GDC47 F17 2010.8 28 ST746 CTX, CIP, FFC, TET
GDC114* F28 2010.9 29 ST48 AMK, CTX, GEN, CIP, FFC, TET
GDC56 F19 2010.8 30a ST359 CTX, GEN, CIP, FFC, TET
GDC58 F23 2010.8 30b ST4461 CTX, CIP, FFC, TET
GDC61 F20 2010.8 31 ST4473 CTX, GEN, FFC, TET
GDC15 F21 2010.8 32 ST4465 CTX, CIP, FFC
GDC16 F21 2010.8 33 ST4474 AMK, CTX, GEN, CIP, FFC, TET
GDC17 F21 2010.8 34 ST1518 CTX, CIP, FFC, TET
GDC24 F15 2010.8 35 ST4477 CTX, CIP, FFC, TET
GDC37 F22 2010.8 36 ST4459 CTX, GEN, FFC, TET
GXC03* F24 2009.7 37 ST2847 CTX, GEN, CIP, FFC, TET
GXC19* F25 2009.7 38 ST4360 CTX, GEN, CIP, FFC, TET
HNC02* F31 2009.7 39 ST4464 AMK, CTX, GEN, FFC, TET
HNC06* F31 2009.7 40 ST779 CTX, TET
SDC20 F35 2009.6 41 ST48 CTX, FFC, TET
SDC10 F32 2009.6 42 ST4498 AMK, CTX, GEN, CIP, FFC, TET
SDC12 F32 2009.6 43 ST4497 AMK, CTX, GEN, CIP, FFC, TET
SDC04 F33 2009.5 44 ST602 CTX, CIP, FFC, TET
SDC01 F34 2009.5 45 ST4462 AMK, CTX, GEN, CIP, FFC, TET
SDC11 F34 2009.6 46 ST602 AMK, CTX, GEN, CIP, TET
SDC15 F36 2009.5 47 ST219 AMK, CTX, GEN, CIP, FFC, TET
GD326 F27 2011.3 48 ST1589 CTX, CIP, FFC, TET
(Continued)
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Table 1 | Continued
Isolatea Farmb Isolation date PFGE patternc MLST Resistance profiled
GDC1-4* F28 2010.9 49 ST453 CTX, GEN, CIP, FFC, TET
GDC240* F29 2010.8 50 ST354 AMK, CTX, GEN, CIP, FFC, TET
GDC540* F29 2010.8 51 ST48 CTX, GEN, FFC, TET
GDC1-2* F28 2010.9 52 ST93 CTX, GEN, CIP, FFC, TET
GDC127* F30 2010.9 smeared ST156 CTX, GEN, CIP, FFC, TET
SDC13 F37 2009.5 smeared ST398 CTX, GEN, CIP, FFC, TET
aDifferent provinces are indicated as follows: AH, Anhui; GD, Guangdong; GX, Guangxi; HN, Henan; SD, Shandong. Isolates from which the fosA3 gene can be
transferred to the recipient by conjugation are underlined. Healthy animals are indicated by an asterisk.
bF1 to F36, farm 1 to farm 36, respectively.
cPFGE types (1, 2, 3, etc.) were assigned by visual inspection of the macrorestriction profile. Patterns that differed by fewer than six bands were considered to
represent subtypes within the main group (30a, 30b, etc.). NT, nontypeable.
d AMK, amikacin; CTX, cefotaxime; CIP, ciprofloxacin; FFC, florfenicol; GEN, gentamicin; TET, tetracycline. The antimicrobial susceptibility results were interpreted
according to breakpoint of CLSI (M100-S23), except that florfenicol (≥32 µg/mL) was interpreted according to breakpoint of European Committee on Antimicrobial
Susceptibility Testing (EUCAST). All isolates were susceptible to colistin, imipenem, piperacillin-tazobactam, and tigecycline. Resistance phenotypes transferred to
the recipient by conjugation ortransformationare underlined.
and amikacin, respectively (Table 1). All isolates were susceptible
to colistin, imipenem, piperacillin-tazobactam, and tigecycline.
Results of screening for resistance genes showed that 57
of the 58 FosA3-producing E. coli isolates carried blaCTX−M
genes, including blaCTX−M−55 (n = 24), blaCTX−M−65 (n = 20),
blaCTX−M−14 (n = 11), blaCTX−M−123 (n = 3), blaCTX−M−3 (n =
2), blaCTX−M−64 (n = 1), and blaCTX−M−15(n = 1). Five isolates
carried two different blaCTX−M genes. In addition, 17 and 52
isolates harbored rmtB and floR genes, respectively.
ANALYSIS OF fosA3 PLASMIDS
fosA3 genes from 50 isolates were successfully transferred by
conjugation. The fosA3-bearing plasmids in the remaining eight
isolates and six transconjugants carrying multiple plasmids were
transferred by transformation. Three transformants carried mul-
tiple plasmids and were not studied further. The 55 fosA3 plas-
mids ranged in size from 45 to 230 kb and contained IncFII (n =
29), IncI1 (n = 9), IncHI2 (n = 12), and IncN (n = 4) replicons
(Table 2). In addition, seven plasmids were fused plasmids, which
contained both IncN and IncFII replicons. The replicon type
for one plasmid could not be determined by the PBRT method.
Interestingly, the majority of IncFII plasmids associated with the
fosA3 gene were classified as F33:A-:B- by RST. Subtyping of IncI1
plasmids revealed three sequence types, including ST71 (n = 3),
ST108 (n = 3), and a new sequence type ST136 (n = 2). The
IncI1 plasmid from isolate AHC60 was not typable because the
trbA and pilL alleles were not detected. Ten IncHI2 plasmids were
assigned to ST3 by pDLST, while the other two IncHI2 plas-
mids were not typable due to failure to detect the smr0199 loci.
By restriction analysis of plasmid DNA using EcoRI, 21 F33:A-
:B- plasmids, eight IncI1 plasmids, and nine IncHI2 plasmids
were divided into 10, eight, and nine groups, respectively, which
exhibited small band differences. The conjugation frequencies of
F33:A-:B- and IncN-F33:A-:B-plasmids were 10−6 to 10−8, while
IncI1 and IncHI2 plasmids were 10−5 to 10−6.
Co-transfer of resistance to other antimicrobials (cefotaxime,
aminoglycosides, florfenicol, and tetracycline) was observed in
54 of the 55 transconjugants/transformants harboring a single
plasmid. blaCTX−M, rmtB, and floR genes were co-transferred with
fosA3 to the recipients from 50, 14, and 19 donors, respectively.
ADDICTION SYSTEMS OF fosA3 PLASMIDS
The 55 fosA3 plasmids carried 0-4 addiction systems (mean 2.4).
Six different systems, namely ccdAB, hok-sok, pemKI, pndAC,
snrBC, and vagCD systems were detected. The most frequently
represented systems were pemKI, followed by vagCD, hok-sok, and
srnBC (Table 2). All F33: A-: B- plasmids except one (AHC9) had
pemKI, hok-sok, and srnBC. The average number of addiction
systems detected was the highest (3.5) among IncFII plasmids,
followed by IncI1 plasmids (2.2), which were significantly higher
than the remaining plasmids (P < 0.01). IncN and IncHI2 plas-
mids were mostly devoid of the addiction systems tested in the
study (Table 2).
GENETIC ENVIRONMENT OF fosA3
The regions surrounding fosA3 were determined by PCR map-
ping and sequencing. Different genetic contexts of fosA3 were
designated as types I–V (Table 2 and Figure 1). An IS26 element
was found to be located downstream of fosA3 in all the iso-
lates except AHC60, AHC8, and GXC03. In these three isolates,
the genetic elements downstream of fosA3 could not be defined.
The sizes of the spacer regions between the 3′ end of fosA3 and
IS26 varied (1758, 536, and 1222 bp; Table 1). Upstream of fosA3,
four different genetic organizations were identified. In 48 iso-
lates, IS26 was located 316 bp upstream of fosA3 (type I, III),
and in 1 isolate (GXC19), IS26 was located 252 bp upstream
of fosA3 (type II). In nine isolates, blaCTX−M−14 was identi-
fied 1135 bp upstream of fosA3 (type IV) or 611 bp upstream
of fosA3 (type V). The type V structure (blaCTX−M−14-611bp-
fosA3-1222bp-IS26) was 100% identical to that found in the
plasmids of ECO021TF (accession no. JQ343849, human E. coli,
Korea, 2009), pHP48 (AB778503, human E. coli, Japan, 2010),
and pN0863T (JQ823170, dog E. coli, Hong Kong, 2008). The
type IV structure (blaCTX−M−14-1135bp-fosA3-1758bp-IS26) was
100% identical to that found in the plasmid of EC0121TF (acces-
sion no. JX442753, chicken E. coli, 2009) from Hong Kong
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Table 2 | Characterization of some plasmids carrying fosA3.
Plasmid(s) Co-transfer of other
resistance gene(s)
Context
of fosA3a
Plasmid
Size (kb) Replicon type EcoRI RFLP b Addiction systems
GDC24, GDC58, AHC18, SDC13,
GDC40, GDC47, GDC1-4,
GDC114, SDC04
blaCTX−M−55 I ∼75 F33:A-:B- A1 hok-sok, pemKI, srnBC
AHC33, GDC240 blaCTX−M−65, rmtB III ∼75 F33:A-:B- A1 hok-sok, pemKI, srnBC
AHC17, AHC26 blaCTX−M−55, rmtB I ∼100 N-F33:A-:B- A2 hok-sok, pemKI, srnBC, vagCD
AHC24 blaCTX−M−55, rmtB, floR I ∼110 N-F33:A-:B- A3 hok-sok, pemKI, srnBC, vagCD
GDC54 blaCTX−M−65 III ∼75 F33:A-:B- A4 hok-sok, pemKI, srnBC, vagCD
AHC23 blaCTX−M−65, rmtB III ∼80 F33:A-:B- A5 hok-sok, pemKI, srnBC
GDC46 blaCTX−M−55 III ∼75 F33:A-:B- A6 hok-sok, pemKI, srnBC, vagCD
SDC01 blaCTX−M−55, rmtB I ∼100 N-F33:A-:B- A7 hok-sok, pemKI, srnBC, vagCD
AHC76 blaCTX−M−55 I ∼75 F33:A-:B- A8 hok-sok, pemKI, srnBC
HNC02 blaCTX−M−65, rmtB III ∼80 F33:A-:B- A9 hok-sok, pemKI, srnBC, vagCD
AHC52 blaCTX−M−55, rmtB, floR I ∼110 N-F33:A-:B- A10 hok-sok, pemKI, srnBC, vagCD
GDC17 blaCTX−M−55, floR I ∼95 N-F33:A-:B- B hok-sok, pemKI, srnBC, vagCD
AHC9 blaCTX−M−55 I ∼65 N-F33:A-:B- C pemKI, srnBC, vagCD
AHC69, AHC72 blaCTX−M−65 I ∼75 F33:A-:B- ND hok-sok, pemKI, srnBC, vagCD
AHC27 blaCTX−M−65 I ∼115 I1/ST71 D1 pemKI, pndCA, vagCD
GDC27 blaCTX−M−65, floR I ∼125 I1/ST71 D2 pemKI
AHC30 blaCTX−M−55, floR I ∼105 I1/ST136 D3 hok-sok, pemKI, pndCA, vagCD
GXC19 blaCTX−M−65, floR II ∼125 I1/ST71 D4 pndCA
AHC54 blaCTX−M−123 I ∼110 I1/ST108 D5 pemKI, pndCA, vagCD
AHC14 blaCTX−M−123 I ∼115 I1/ST108 D6 pndCA
AHC55 blaCTX−M−123 I ∼110 I1/ST108 D7 hok-sok, pemKI, pndCA
SDC11 blaCTX−M−14, rmtB V ∼100 I1/ST136 D8 pemKI, pndCA
AHC60 rmtB Unknown ∼120 I1 E pndCA, vagCD
AHC66, AHC67 blaCTX−M−65, floR I ∼230 HI2/ST3 F1 none
AHC57 blaCTX−M−14, floR IV ∼230 HI2/ST3 F2 none
AHC80 blaCTX−M−14, rmtB, floR IV ∼230 HI2/ST3 ND vagCD
GDC540 blaCTX−M−14, floR V ∼230 HI2/ST3 F3 pemKI, vagCD
GDC15 blaCTX−M−65, floR III ∼230 HI2/ST3 F4 none
GDC61 blaCTX−M−14, floR IV ∼230 HI2 F5 pemKI, vagCD
GXC03 blaCTX−M−15 Unknown ∼230 HI2/ST3 F6 vagCD
GDC127 blaCTX−M−14, floR V ∼230 HI2/ST3 F7 none
HNC06 blaCTX−M−14 V ∼230 HI2/ST3 F8 vagCD
GD326 blaCTX−M−14, floR V ∼230 HI2 F9 none
SDC20 blaCTX−M−65, floR I ∼230 HI2/ST3 ND none
SDC10, SDC12 rmtB, floR I ∼45 N ND none
SDC15 rmtB I ∼50 N ND vagCD
AHC51 blaCTX−M−65 I ∼50 N ND none
GDC1-2 blaCTX−M−3, floR I ∼75 F2:A-:B- ND hok-sok, pemKI, vagCD
GDC56 blaCTX−M−3 I ∼75 F14:A-:B- ND hok-sok, pemKI, vagCD
AHC12 blaCTX−M−65, floR I ∼80 F18:A-:B- ND pemKI, srnBC, vagCD, ccdAB
AHC16 blaCTX−M−14, floR I ∼80 F18:A-:B- ND pemKI, srnBC, ccdAB
GDC16 I ∼70 unknown ND vagCD
aContexts of fosA3 were as follows: I, IS26-316bp-fosA3-1758bp-IS26; II, IS26-316bp-fosA3-536bp-IS26; III, blaCTX−M−14-1135bp-fosA3-1758bp-IS26; IV,
blaCTX−M−14-611bp-fosA3-1222bp-IS26.
bRestriction fragment length polymorphism (RFLP) patterns differed by only a few bands (n = 1–3) were assigned to the same RFLP profile. ND, not determined.
and was found to be located on IncHI2 plasmids. IncHI2 was
also found to be associated with type V structures. However,
type I and type III structures were usually found to be asso-
ciated with F33:A-:B- and IncI1 plasmids. In 15 F33:A-:B- or
N-F33:A-:B- plasmids, a structure comprising IS26, truncated
ISEcp1, blaCTX−M−55, orf477, and a truncated blaTEM−1, was
found upstream of the type I structure. This genetic environment
surrounding the fosA3 gene was 100% in sequence identity
to the plasmid carried by E. coli HP558 (AB778291, human
E. coli, 2010) from Japan. Also, in five F33:A-:B- plasmids and
four IncI1 plasmids, a structure comprising IS26, truncated
ISEcp1, blaCTX−M−65, IS903, and iroN was found upstream of
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FIGURE 1 | Schematic representation of the genetic contexts of fosA3 gene. Regions of 100% homology are shaded in gray.
the type I structure and type III structure, respectively. The
genetic structure (ISEcp1-blaCTX−M−65-IS903-iroN-IS26-316bp-
fosA3-536bp-IS26) located on F33:A-:B- plasmids was almost
identical to those found in plasmids pXZ (JF927996, duck
E. coli, 2008) and pHN7A8 (JN232517, dog E. coli, 2008) from
China. The genetic structure (ISEcp1-blaCTX−M−65-IS903-iroN-
IS26-252bp-fosA3-1758bp-IS26) carried by IncI1 plasmids rep-
resented a novel genetic environment and was first identified in
this study. In one isolate with the type III fosA3 context, the IS26
downstream of fosA3 was truncated by another IS26.
DISCUSSION
In this study, we investigated the prevalence of fosfomycin resis-
tance in E. coli isolated from chickens from 2009 to 2011 in
China. Our previous study showed that fosfomycin resistance
was unusual among E. coli isolates from food animals during
the period from 2004 to 2008 (Hou et al., 2013). However, in
this study, fosfomycin resistance was detected in 8.8% of E. coli
isolates from chickens. This frequency was significantly higher
than that reported in other countries (Karageorgopoulos et al.,
2012; Karlowsky et al., 2014), and also higher than that in
isolates from humans in China (Lai et al., 2014). Fosfomycin
is not approved for use in food animals in China. Thus, the
high frequency of fosfomycin resistance found in this study was
unexpected and was not due to the selective pressure resulting
from exposure to fosfomycin. Coselection by other antimicro-
bials, especially third-generation cephalosporins, seemed to play
a major role in facilitating the spread of this plasmid-mediated
fosfomycin-resistance determinant since almost all fosA3 plas-
mids also carried blaCTX−M genes. In addition, the intensive use
of florfenicol and gentamicin might also have favored the dis-
semination of fosA3 in the chicken population as florfenicol-
and gentamicin-resistance genes were usually co-transferred with
fosA3. Other studies also observed the cotransfer of blaCTX−M
genes with the fosA3 gene and the cotransfer of chlorampheni-
col resistance (Hou et al., 2012, 2013; Ho et al., 2013a; Sato et al.,
2013; Lai et al., 2014).
Most of the fosA3-positive isolates (48/58) found in this study
were recovered from diseased chickens. Generally, chicken farm-
ers will use antimicrobial agents to control diseases; if such disease
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controls fail, they will send the diseased animals to diagnostic lab-
oratories for diagnosis and treatment. Thus, the diseased chickens
have most likely been subjected to more serious antimicrobial
selective forces than healthy chickens before they are sent to diag-
nostic laboratories, suggesting that other antimicrobials may be
the driving force for the observed increase in fosfomycin resis-
tance and may affect the dissemination of fosA3 in chickens. In
support of this, we surveyed the antimicrobial usage history of
15 farms (data not shown) and found that cephalosporins and
florfenicol were frequently used in most chicken farms.
The spread of the fosA3 gene among E. coli isolates of chicken
origin was not attributed to clonal transfer of FosA3-producers,
but was instead caused by several epidemic plasmids, including
F33:A-:B-, IncI1/ST108, IncI1/ST71, and IncHI2/ST3 plasmids,
which have been disseminated in multiple chicken farms found
in different geographic regions of China.
The combination of fosA3 and F33:A-:B- plasmids has been
frequently identified in several Asia countries (Hou et al., 2012,
2013; Lee et al., 2012; Sato et al., 2013; Pan et al., 2014). In our
previous study on isolates from pets and food animals collected
during the period from 2004 to 2008, fosA3 genes usually co-
existed with baCTX−M−65 on F33:A-:B- plasmids (Hou et al., 2012,
2013). However, in this study, fosA3 genes frequently co-existed
with blaCTX−M−55 on a similar or identical genetic structure
carried by F33:A-:B- plasmids, similar to that of the two F33:A-
:B- plasmids found in Japan and Korea (Lee et al., 2012; Sato
et al., 2013). These data indicated that F33:A-:B- plasmids car-
rying identical or similar mobile multiresistance regions have
disseminated in animals and humans in different Asian coun-
tries. Therefore, these plasmids are capable of spreading very
efficiently andmay be themajor vehicle contributing to the spread
of the fosA3 gene. The successful dissemination of F33:A-:B- plas-
mids may be attributed to the presence of addiction systems
(pemKI, hok-sok, srnBC), which ensure the stable maintenance
of the plasmid during cell division (Hou et al., 2012; He et al.,
2013b). Though the F33:A-:B- plasmid has only been identified in
Asian countries, it may be possible for the plasmid to disseminate
worldwide by international travel or animal and food trade.
IncI1 plasmids carrying fosA3 have previously been reported
in China and Japan (Hou et al., 2013; Sato et al., 2013). In this
study, three different IncI1 pMLST plasmid types were associated
with fosA3, namely ST71, ST108, and ST136. Three ST71 plas-
mids from different provinces (Anhui, Guangxi, and Guangdong)
carried both fosA3 and blaCTX−M−65. Interestingly, ST71 carry-
ing blaCTX−M−14 and fosA3 was also detected in isolates from
humans in Japan (Sato et al., 2013). ST108, first reported in our
previous study as a blaCTX−M−123 carrier (He et al., 2013a), also
harbored blaCTX−M−123 in this study. In a pig farm in the United
Kingdom, the ST108 IncI1 plasmid carrying the blaCTX−M−1
gene had disseminated across multiple genera (Freire Martin
et al., 2014). IncHI2 plasmids have been found to be associated
with ESBL genes in Enterobacteriaceae, but were more common
in Salmonella enterica than in E. coli (Garcia-Fernandez and
Carattoli, 2010). This study reported the identification of fosA3
genes on IncHI2 plasmids for the first time. Most fosA3 genes
in IncHI2 plasmids have similar genetic environments, mainly
blaCTX−M−14-fosA3-IS26. However, this structure was located on
the IncN plasmid in one isolate from Korea (Lee et al., 2012).
Our findings revealed that the mobile element IS26 and co-
selection with blaCTX−M genes played a critical role in the rapid
transfer of the fosA3 gene between diverse epidemic plasmids.
Since fosA3 can be carried by several successfully disseminated
plasmids (F33:A-:B-, ST108/ST71 IncI1, and ST3 IncHI2) and
CTX-M-type ESBL producers are distributed globally in a variety
of settings (Woerther et al., 2013), we should pay close attention
to the worldwide dissemination of fosA3 in the near future. More
studies are required to investigate the spread of fosA3 gene in other
countries as well as in other hosts and environments.
In conclusion, our study reported a surprisingly high preva-
lence of the plasmid-mediated fosfomycin-resistance gene fosA3
in E. coli isolates from chicken in China. Fosfomycin has become
one of the limited treatment options for critically ill patients with
multidrug-resistant bacteria, especially carbapenem-resistant
gram-negative bacteria (Dortet et al., 2014), further spread
of the fosA3 gene would be a serious public health concern.
Measures must be implemented to avoid the selection and spread
of fosfomycin-resistant strains. Since the fosA3 gene is usually
cotransferred with blaCTX−M−55, blaCTX−M−65, blaCTX−M−14,
floR, and rmtB genes on several epidemic plasmids, reduction
in total antimicrobial use, particularly cephalosporins, in food
animal production in China may help to control the spread of
plasmid-mediated fosfomycin-resistance genes.
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